{
  "openalex_id": "W4367047747",
  "doi": "https://doi.org/10.1001/jamadermatol.2023.0797",
  "title": "Validation of the Hidradenitis Suppurativa Investigator Global Assessment",
  "abstract": "Importance Few simplified instruments exist for use in hidradenitis suppurativa (HS) trials. Objective To assess psychometric properties of the Hidradenitis Suppurativa Investigator Global Assessment (HS-IGA) score using a clinical trial data set. Design, Setting, and Participants This retrospective analysis of a phase 2 randomized double-blind, placebo-controlled, active-reference arm trial (UCB HS0001) included adults with moderate-to-severe HS. Exposures Trial participants were randomized at baseline to receive bimekizumab, adalimumab, or placebo. Main Outcomes and Measures The HS-IGA score at prespecified time points up to 12 weeks after randomization. Results The HS-IGA score showed strong convergent validity with IHS4 and HS-PhGA scores at baseline (Spearman correlation, 0.86 [ P &amp;amp;lt; .001] and 0.74 [ P &amp;amp;lt; .001], respectively) and at week 12 (Spearman correlation, 0.73 [ P &amp;amp;lt; .001] and 0.64 [ P &amp;amp;lt; .001], respectively). The HS-IGA scores assessed during predosing visits at screening and baseline showed good test-retest reliability (intraclass correlation coefficient [ICC] = 0.92). At week 12, HS-IGA responders were significantly associated with HiSCR-(50/75/90) responders (χ 2 = 18.45; P &amp;amp;lt; .001; χ 2 = 18.11; P &amp;amp;lt; .001; and χ 2 = 20.83; P &amp;amp;lt; .001, respectively). The HS-IGA score was predictive of HiSCR-50/75/90 and HS-PhGA response at week 12 (AUC, 0.69, 0.73, 0.85, and 0.71, respectively). However, the HS-IGA as a measure of disease activity showed low predictive validity with patient-reported outcomes at week 12. Conclusions and Relevance The HS-IGA score demonstrated good psychometric properties compared with existing measures and may be considered for use as an end point in clinical trials for HS.",
  "authors": [
    {
      "display_name": "Amit Garg",
      "id": "A5043587456",
      "orcid": "https://orcid.org/0000-0003-0886-6856",
      "institutions": [
        {
          "id": "I4210106353",
          "display_name": "Donald & Barbara Zucker School of Medicine at Hofstra/Northwell",
          "country_code": "US",
          "type": "education"
        }
      ],
      "is_corresponding": true,
      "raw_author_name": "Amit Garg"
    },
    {
      "display_name": "Carla L. Zema",
      "id": "A5033821866",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Carla Zema"
    },
    {
      "display_name": "Valérie Ciaravino",
      "id": "A5020844538",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210103390",
          "display_name": "UCB Pharma (France)",
          "country_code": "FR",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Valerie Ciaravino"
    },
    {
      "display_name": "Robert Rolleri",
      "id": "A5012558706",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210127098",
          "display_name": "UCB Pharma (United States)",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Robert Rolleri"
    },
    {
      "display_name": "Luke Peterson",
      "id": "A5070324838",
      "orcid": "https://orcid.org/0000-0003-2581-5655",
      "institutions": [
        {
          "id": "I4210127098",
          "display_name": "UCB Pharma (United States)",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Luke Peterson"
    },
    {
      "display_name": "Llenalia Garcia",
      "id": "A5003350491",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210134054",
          "display_name": "UCB Pharma (United Kingdom)",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Llenalia Garcia"
    },
    {
      "display_name": "Tyler Massaro",
      "id": "A5026938977",
      "orcid": "https://orcid.org/0000-0001-9201-4589",
      "institutions": [
        {
          "id": "I4210127098",
          "display_name": "UCB Pharma (United States)",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Tyler Massaro"
    },
    {
      "display_name": "Gregor B. E. Jemec",
      "id": "A5087050293",
      "orcid": "https://orcid.org/0000-0002-0712-2540",
      "institutions": [
        {
          "id": "I4210087803",
          "display_name": "Zealand University Hospital",
          "country_code": "DK",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Gregor B. E. Jemec"
    },
    {
      "display_name": "Joslyn S. Kirby",
      "id": "A5000796908",
      "orcid": "https://orcid.org/0000-0002-6741-3796",
      "institutions": [
        {
          "id": "I82783531",
          "display_name": "Penn State Milton S. Hershey Medical Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Joslyn S. Kirby"
    },
    {
      "display_name": "Linnea Thorlacius",
      "id": "A5026596462",
      "orcid": "https://orcid.org/0000-0002-3734-9607",
      "institutions": [
        {
          "id": "I4210087803",
          "display_name": "Zealand University Hospital",
          "country_code": "DK",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Linnea Thorlacius"
    },
    {
      "display_name": "J.R. Ingram",
      "id": "A5035195162",
      "orcid": "https://orcid.org/0000-0002-5257-1142",
      "institutions": [
        {
          "id": "I2800861664",
          "display_name": "University Hospital of Wales",
          "country_code": "GB",
          "type": "healthcare"
        },
        {
          "id": "I79510175",
          "display_name": "Cardiff University",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "John R. Ingram"
    }
  ],
  "publication_year": 2023,
  "publication_date": "2023-04-26",
  "type": "article",
  "cited_by_count": 12,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S146641495",
    "display_name": "JAMA Dermatology",
    "issn_l": "2168-6068",
    "issn": [
      "2168-6068",
      "2168-6084"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320259"
  },
  "volume": "159",
  "issue": "6",
  "first_page": "606",
  "last_page": "606",
  "open_access": {
    "is_oa": true,
    "oa_status": "hybrid",
    "oa_url": "https://jamanetwork.com/journals/jamadermatology/articlepdf/2804248/jamadermatology_garg_2023_oi_230012_1682089572.90963.pdf",
    "any_repository_has_fulltext": true
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.92122185
    },
    {
      "id": "C2776002364",
      "display_name": "Hidradenitis suppurativa",
      "level": 3,
      "score": 0.82183456
    },
    {
      "id": "C104709138",
      "display_name": "Intraclass correlation",
      "level": 3,
      "score": 0.7214989
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.6047058
    },
    {
      "id": "C204243189",
      "display_name": "Randomization",
      "level": 3,
      "score": 0.51533836
    },
    {
      "id": "C27081682",
      "display_name": "Placebo",
      "level": 3,
      "score": 0.5033054
    },
    {
      "id": "C168563851",
      "display_name": "Randomized controlled trial",
      "level": 2,
      "score": 0.48317352
    },
    {
      "id": "C2780132546",
      "display_name": "Adalimumab",
      "level": 3,
      "score": 0.45988995
    },
    {
      "id": "C90924648",
      "display_name": "Gastroenterology",
      "level": 1,
      "score": 0.40274972
    },
    {
      "id": "C1862650",
      "display_name": "Physical therapy",
      "level": 1,
      "score": 0.33047587
    },
    {
      "id": "C171606756",
      "display_name": "Psychometrics",
      "level": 2,
      "score": 0.19803947
    },
    {
      "id": "C2779134260",
      "display_name": "Disease",
      "level": 2,
      "score": 0.11228734
    },
    {
      "id": "C142724271",
      "display_name": "Pathology",
      "level": 1,
      "score": 0.07526708
    },
    {
      "id": "C70410870",
      "display_name": "Clinical psychology",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C204787440",
      "display_name": "Alternative medicine",
      "level": 2,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T12731",
      "display_name": "Hidradenitis Suppurativa and Treatments",
      "score": 1.0
    },
    {
      "id": "T13110",
      "display_name": "Colorectal and Anal Carcinomas",
      "score": 0.9692
    },
    {
      "id": "T13569",
      "display_name": "Microscopic Colitis",
      "score": 0.9523
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1001/jamadermatol.2023.0797",
  "pdf_url": "https://jamanetwork.com/journals/jamadermatology/articlepdf/2804248/jamadermatology_garg_2023_oi_230012_1682089572.90963.pdf",
  "retrieved_date": "2025-07-30T14:35:06.481997",
  "source_database": "OpenAlex"
}